Webinar details
Thursday, November 20, 2025
10am EST (NA) / 3pm GMT (UK) / 4pm CET · 60 min
The production of cell and gene therapies requires strict adherence to regulatory standards that ensure patient safety and product consistency. However, sourcing high-performing, animal-free raw materials that meet these standards remains a major challenge for many manufacturers.
In this webinar, we will share validated solutions using Recombinant Insulin and Trypsin that enable compliant, high-quality, animal-free manufacturing. Discover how these innovations can enhance cell proliferation, viral vector production, and overall process reliability while supporting global regulatory compliance.
This webinar is designed for professionals in research, procurement, quality assurance, engineering, and product management within the Regenerative Medicine field.
Speakers
Sara Bursomanno, PhD, Senior Global Product Manager
Sara Bursomanno is a seasoned expert in Cancer Biology with over a decade of experience in academic research. Having transitioned to the biopharmaceutical industry over six years ago, Sara has excelled as a Product Manager, focusing on the upstream manufacturing of biological drugs.
Her specialized knowledge in cell culture and protein production allows her to effectively bridge the gap between scientific research and practical industry applications.
Chantale Julien, Global Product Manager
With over 20 years of experience in the pharmaceutical industry, Chantale is currently a Global Product Manager at Novo Nordisk Pharmatech A/S, where she manages several product portfolios.
Her role encompasses providing technical and scientific support, strategic market positioning and adherence to GXP requirements.
Throughout her career, she has held positions at the Canadian Food Inspection Agency, Novonesis (previously Chr. Hansen A/S) and Cook Medical, in various management roles that emphasize compliance, life-cycle product management and API distribution.
Mrs. Julien earned her Master’s degree in Animal Sciences from Université Laval in Québec, Canada.
